Clinical Trial Update: Intranasal Oxytocin for the Treatment of Children and Adolescents With Autism Spectrum Disorders (ASD) [Phase 2]

View source ↗

Summary

Phase 2 clinical trial evaluating intranasal oxytocin for treatment of children and adolescents with autism spectrum disorders. The study is completed and resul…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Autism Spectrum Disorder

Drugs mentioned

• intranasal oxytocin (oxytocin)

Snippet

Sponsor: Holland Bloorview Kids Rehabilitation Hospital | Conditions: Autism Spectrum Disorder | Phase 2 | Status: COMPLETED | Results posted: 2020-11-16